Equities

Metropolis Healthcare Ltd

METROPOLIS:NSI

Metropolis Healthcare Ltd

Actions
Health CareMedical Equipment and Services
  • Price (INR)1,947.00
  • Today's Change-9.05 / -0.46%
  • Shares traded246.59k
  • 1 Year change+54.77%
  • Beta0.6757
Data delayed at least 15 minutes, as of May 23 2024 09:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Metropolis Healthcare Limited is an India-based company, which is engaged in providing diagnostic services. The Company operates through the pathology services segment. The Company offers a range of clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. The Company also offers analytical and support services to clinical research organizations for their clinical research projects. Its services include pathology testing services, corporate wellness, lab in hospitals and clinical research services. The Company offers a range of tests and profiles that include advanced tests in diagnosis of cancer, neurological disorders, infectious diseases, and an array of genetic abnormalities. It owns a chain of diagnostic centers across India, South Asia, Africa, and the Middle East. The Company has spread its footprint across 20 Indian states and over 220 cities.

  • Revenue in INR (TTM)12.08bn
  • Net income in INR1.28bn
  • Incorporated2000
  • Employees4.29k
  • Location
    Metropolis Healthcare LtdNh-8, Sco No. 30, Sector 15, Part IiMUMBAI 400018IndiaIND
  • Phone+91 8 422801801
  • Fax+91 2 256622080
  • Websitehttps://www.metropolisindia.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Indraprastha Medical Corporation Ltd12.45bn1.24bn22.44bn2.95k18.104.7013.681.8013.5213.52135.7652.121.9566.2219.66--19.3912.7425.2117.0457.4957.379.966.731.8237.750.066429.1313.299.5743.8934.2632.3422.98
Artemis Medicare Services Ltd8.79bn491.41m24.93bn1.94k51.445.5627.872.843.543.5463.0232.750.93640.009.20--5.24--6.66------5.594.590.92082.950.4133--19.149.9627.3219.12----
Shalby Ltd8.88bn813.79m29.18bn2.68k35.86--22.303.287.597.5982.90--------3,317,771.00--4.28--4.8146.4271.659.167.74--9.23--20.3015.1616.3225.0811.45-33.14--
Thyrocare Technologies Ltd5.72bn707.70m33.19bn1.65k46.746.3028.495.8013.4113.41108.0899.520.89594.438.89--10.8918.1712.5520.9770.8569.8112.1519.562.5526.830.074383.568.587.269.94-3.638.88-2.09
Yatharth Hospital & Trauma Cre Srvcs Ltd-100.00bn-100.00bn37.76bn--------------------------------------------------29.77--48.92------
Healthcare Global Enterprises Ltd18.56bn352.59m49.86bn5.50k142.05--25.692.692.522.52132.66--------3,371,374.00---3.20---4.3553.2154.191.27-5.21--1.30----21.2715.28-45.387.42-12.26--
Jupiter Life Line Hospitals Ltd10.70bn1.77bn75.09bn3.14k39.976.4234.297.0228.6528.65171.06178.300.94369.3920.79--15.58--17.39--82.28--16.51--3.677.430.00--19.83--142.25------
Vijaya Diagnostic Centre Ltd5.48bn1.19bn80.06bn2.00k67.3812.1645.3314.6111.5911.5953.4464.210.596718.1042.58--13.0314.1014.1415.5488.0586.4121.8421.202.836.830.2826.6619.3413.3740.4020.977.58--
Metropolis Healthcare Ltd12.08bn1.28bn100.21bn4.29k78.629.1444.958.3024.8824.88235.10213.970.79026.159.73--8.4013.6510.1116.9478.7975.7310.6414.661.138.350.152--5.189.67-10.541.2521.84--
Rainbow Children's Medicare Ltd12.97bn2.17bn127.82bn3.58k58.9010.1538.699.8621.3821.38127.78124.030.65817.7321.29--11.089.8911.9910.9687.2683.5116.8313.804.005.360.377--10.5119.032.9337.2332.22--
Krishna Institute Of Medical Sciencs Ltd24.98bn3.10bn152.50bn10.00k49.168.3431.596.1038.7638.76312.20228.460.735511.499.13--9.9013.7112.2016.7378.7761.4213.4615.531.1010.440.393--13.6722.17-7.78--52.94--
Aster DM Healthcare Ltd135.05bn3.24bn176.91bn24.65k54.55--13.701.316.516.51272.61--------5,478,007.00--3.41--5.1162.0161.382.934.08--2.25----16.3812.17-19.229.5810.29--
Data as of May 23 2024. Currency figures normalised to Metropolis Healthcare Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

34.95%Per cent of shares held by top holders
HolderShares% Held
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 30 Apr 20244.24m8.28%
UTI Asset Management Co. Ltd. (Investment Management)as of 31 Dec 20233.37m6.57%
JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Apr 20242.00m3.91%
Franklin Templeton Asset Management (India) Pvt Ltd.as of 30 Apr 20241.73m3.38%
Grandeur Peak Global Advisors LLCas of 23 Aug 20231.45m2.83%
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 30 Apr 20241.41m2.76%
First Sentier Investors (Singapore)as of 31 Jan 20241.24m2.42%
The Vanguard Group, Inc.as of 09 May 20241.02m1.99%
JPMorgan Asset Management (UK) Ltd.as of 30 Apr 2024792.40k1.55%
SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 29 Feb 2024651.10k1.27%
More ▼
Data from 29 Feb 2024 - 16 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.